A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?

A Solana-Altabella, R Rodríguez-Veiga… - Annals of …, 2024 - Springer
Acute myeloid leukemia (AML) is an aggressive hematological disease that mainly affects
elderly patients. Following the randomized VIALE-A trial, current standard treatment in …

Psychiatric Disorders, SUDs Diminish Venetoclax Outcomes in Veterans With AML.

B Furlow - Oncology Nurse Advisor, 2023 - go.gale.com
Psychiatric and substance use disorders (SUDs) hinder remission and survival rates among
military veterans taking frontline venetoclax-based combinations for acute myeloid leukemia …